Rewards

Regeneron Pharmaceuticals Inc (REGN)

Underlying price

$745.65

+0.82% today

Stock stats

Market cap
$76.1B
Previous close
$739.57
Open
$737.20
Day's range
$732.83 – $751.27
52-week range
$541.00 – $859.34
Volume
321K
Avg volume
723K
P/E ratio
17.65

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Ticker
REGN
Asset class
Equity
Tokenized by
1 issuer
Sector
Healthcare
Industry
Pharmaceutical Preparations
Employees
15,410

Regeneron Pharmaceuticals Inc FAQ

REGN is Regeneron Pharmaceuticals Inc stock, issued on Solana as a token that tracks the listed share. Each issuer mints its own version, so Regeneron Pharmaceuticals Inc trades here as one token.